1st Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
Client
Income
$201,227
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Pharmacy PHA

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA)

Consumer Issues/Safety/Products CSP

- The SHOP SAFE Act

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1219 (119th)

Manufacturing MAN

- Pharmaceutical Tariffs

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.